Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer
Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer is a paper indexed in PICO Portal from OpenAlex.
How many citations does Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer have?
Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer has 987 citations in the OpenAlex counts PICO Portal stores.
When was Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer published?
Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer has 2018 year in the PICO Portal index.
What is the open-access status of Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer?
Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer has bronze oa status in the PICO Portal index.
What is the DOI of Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer?
The DOI for Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer is on the source record.
What is the PMID of Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer?
The PMID for Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer is on the source record.
What is the OpenAlex record for Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer?
The OpenAlex for Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer is on the source record.